Avid Bioservices, Inc. (CDMO) Financials

CDMO Assets vs Liabilities

DateAssetsLiabilities
2023-10-31 454.6 million 271.0 million
2023-07-31 442.3 million 251.7 million
2023-04-30 451.1 million 261.6 million
2023-01-31 450.4 million 265.0 million

CDMO Free Cash Flow and Stock based compensation

No data available :(

CDMO Net Income

No data available :(

CDMO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-10-31 31.4 million - 54.1 million
2023-07-31 24.9 million - 48.1 million
2023-04-30 38.5 million 140.6 million 48.6 million
2023-01-31 59.9 million 140.4 million 40.4 million

CDMO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-10-31 63.1 million
2023-07-31 62.8 million
2023-04-30 62.6 million
2023-01-31 63.7 million

CDMO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-10-31 7.3 million - 6.6 million -
2023-07-31 14.1 million - 6.3 million -
2023-04-30 24.9 million - 6.9 million 700000
2023-01-31 11.3 million - 7.1 million -

CDMO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-10-31 25.4 million 30.1 million
2023-07-31 37.7 million 33.6 million
2023-04-30 39.8 million 31.4 million
2023-01-31 38.0 million 28.2 million

CDMO

Price: $7.67

52 week price:
4.07
21.05

Earnings Per Share: -0.18 USD

P/E Ratio: -36.78

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 451500

Ebitda: -12.0 million

Market Capitalization: 436.4 million

Links: